Immunohistochemistry analysis of prostate carcinomas 72 h post-irradiation showed increased expression of the immunoproteosome components LMP2 and LMP7, the peptide transporter TAP2, and the chaperones tapasin and calreticulin (Fig. 4). The gene discussed is TAPBP; the disease is prostate carcinoma.